BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8649370)

  • 1. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C.
    Molkentin JD; Black BL; Martin JF; Olson EN
    Mol Cell Biol; 1996 Jun; 16(6):2627-36. PubMed ID: 8649370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity.
    Molkentin JD; Li L; Olson EN
    J Biol Chem; 1996 Jul; 271(29):17199-204. PubMed ID: 8663403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEF2B is a potent transactivator expressed in early myogenic lineages.
    Molkentin JD; Firulli AB; Black BL; Martin JF; Hustad CM; Copeland N; Jenkins N; Lyons G; Olson EN
    Mol Cell Biol; 1996 Jul; 16(7):3814-24. PubMed ID: 8668199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-dependent recruitment of MEF2 proteins to target promoters.
    Morin S; Charron F; Robitaille L; Nemer M
    EMBO J; 2000 May; 19(9):2046-55. PubMed ID: 10790371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptional activity.
    Yu YT
    J Biol Chem; 1996 Oct; 271(40):24675-83. PubMed ID: 8798735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding specificity determinants in MADS-box transcription factors.
    Nurrish SJ; Treisman R
    Mol Cell Biol; 1995 Aug; 15(8):4076-85. PubMed ID: 7623803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the MEF2 family of transcription factors by p38.
    Zhao M; New L; Kravchenko VV; Kato Y; Gram H; di Padova F; Olson EN; Ulevitch RJ; Han J
    Mol Cell Biol; 1999 Jan; 19(1):21-30. PubMed ID: 9858528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.
    Martin JF; Miano JM; Hustad CM; Copeland NG; Jenkins NA; Olson EN
    Mol Cell Biol; 1994 Mar; 14(3):1647-56. PubMed ID: 8114702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.
    Zhu B; Ramachandran B; Gulick T
    J Biol Chem; 2005 Aug; 280(31):28749-60. PubMed ID: 15834131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2.
    Han A; Pan F; Stroud JC; Youn HD; Liu JO; Chen L
    Nature; 2003 Apr; 422(6933):730-4. PubMed ID: 12700764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations within the conserved MADS box of the D-MEF2 muscle differentiation factor result in a loss of DNA binding ability and lethality in Drosophila.
    Nguyen T; Wang J; Schulz RA
    Differentiation; 2002 Oct; 70(8):438-46. PubMed ID: 12366381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57.
    Kobarg CB; Kobarg J; Crosara-Alberto DP; Theizen TH; Franchini KG
    FEBS Lett; 2005 May; 579(12):2615-22. PubMed ID: 15862299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.
    Choi SJ; Park SY; Han TH
    Nucleic Acids Res; 2001 Jul; 29(13):2836-42. PubMed ID: 11433030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells.
    Ornatsky OI; McDermott JC
    J Biol Chem; 1996 Oct; 271(40):24927-33. PubMed ID: 8798771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.
    Han A; He J; Wu Y; Liu JO; Chen L
    J Mol Biol; 2005 Jan; 345(1):91-102. PubMed ID: 15567413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2.
    Black BL; Molkentin JD; Olson EN
    Mol Cell Biol; 1998 Jan; 18(1):69-77. PubMed ID: 9418854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional regulatory regions of human transcription factor MEF2C.
    Janson CG; Chen Y; Li Y; Leifer D
    Brain Res Mol Brain Res; 2001 Dec; 97(1):70-82. PubMed ID: 11744164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.
    Zhang CL; McKinsey TA; Lu JR; Olson EN
    J Biol Chem; 2001 Jan; 276(1):35-9. PubMed ID: 11022042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation.
    Gong XQ; Li L
    J Biol Chem; 2002 Apr; 277(14):12310-7. PubMed ID: 11809751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.